Related Experiment Video

Updated: Jun 27, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

The calf model of immunity for development of a vaccine against tuberculosis

Janice J Endsley1, W Ray Waters, Mitchell V Palmer

  • 1University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, United States.

Veterinary Immunology and Immunopathology
|November 26, 2008
PubMed

Insights

The bovine neonate model shows promise for evaluating tuberculosis (TB) vaccines in young children. Studies suggest this model closely mimics human immune responses to TB vaccines, aiding in the development of new TB preventatives.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Veterinary Medicine

Background:

  • Tuberculosis (TB) remains a significant global public health challenge, necessitating novel vaccine strategies beyond Mycobacterium bovis bacille Calmette-Guérin (BCG).
  • The human immunodeficiency virus (HIV) pandemic further underscores the need for effective TB vaccines, particularly for vulnerable populations like newborns and young children.
  • Current animal models may not fully replicate the immune responses and disease progression relevant to vaccinating young humans.

Purpose of the Study:

  • To evaluate the bovine neonate and adolescent as a preclinical animal model for assessing the safety and efficacy of TB vaccine candidates.
  • To compare immune responses and disease pathology in bovine neonates and non-human primates using a novel auxotrophic mutant TB vaccine.

Main Methods:

  • Parallel studies were conducted in bovine neonates and non-human primates using a leading auxotrophic mutant TB vaccine candidate.
  • Comparative analysis of gross pathology, lung lesions, and immune cell responses (IFN-gamma, FoxP3, IL-4) was performed relative to BCG vaccination.

Main Results:

  • The bovine model demonstrated findings comparable to non-human primates regarding gross pathology scoring when compared to BCG.
  • Bovine neonates vaccinated with the auxotrophic mutant showed more numerous and severe lung lesions and higher levels of IFN-gamma producing cells.
  • BCG vaccination in bovines resulted in elevated FoxP3 transcripts and decreased IL-4 mRNA levels.

Conclusions:

  • The bovine neonate and adolescent model is proposed as a robust platform for preclinical evaluation of TB vaccines intended for young children.
  • This model's ability to approximate human immune function and disease progression offers a valuable tool for developing next-generation TB vaccines.
  • Further research in this model can accelerate the development of safe and effective TB vaccines for vulnerable pediatric populations.

More Related Videos

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...